LANCET CAPITAL
Lancet Capital, the first SBIC affiliated with an academic medical center, was founded in 1998 by William Golden and George Sing to create value for investors and founders/management of early stage biomedical portfolio companies. Lancet invests in exceptional researchers, clinicians and entrepreneurs to commercialize innovative technologies in the biomedical field.
LANCET CAPITAL
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx Euro
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-03-05 | ETHA Lend | Lancet Capital investment in Seed Round - ETHA Lend | 1.6 M USD |
| 2002-07-15 | Scion Pharmaceuticals | Lancet Capital investment in Series B - Scion Pharmaceuticals | 17.5 M USD |